Biomet Hip Lawsuits Move Forward, As Bernstein Liebhard LLP Reports on Latest Case Management Conference in Federal Biomet Hip Replacement Litigation


New York, New York (PRWEB) July 01, 2013

Hundreds of Biomet hip lawsuits involving the Biomet M2a Magnum Hip Replacement Program continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Northern District of Indiana. According to a Memorandum issued by the Court on June 24th, the Biomet hip replacement litigations most recent case management conference was held on June 17, 2013, at which time a quantity of issues had been addressed, including pending motions to strike affirmative defenses, jurisdictional issues connected to the current dismissal of improperly named defendants, and the use of a kind complaint. At the conclusion of the conference, the parties presented a tutorial on the scientific and technical issues involved in the Biomet hip replacement lawsuits. (In re: Biomet M2a Magnum Hip Implant Items Liability Litigation MDL No. 2391)

&#13

This most current conference addressed a number of crucial concerns. We are pleased to see the Biomet hip replacement litigation moving ahead, and look forward to extra progress in the future, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and healthcare devices. The Firm is representing customers in Biomet hip lawsuits in the federal multidistrict litigation, and continues to supply free of charge and confidential case evaluations to people who may possibly have been injured by Biomet M2a Magnum implants.

&#13

Biomet Hip Replacement Lawsuits&#13

Court documents indicate that far more than 300 Biomet hip lawsuits are now pending in the federal multidistrict litigation. All of the claims allege the Biomet M2a Magnum implants metal-on-metal design can shed dangerous amounts of toxic metal debris as a outcome of wear, top to metallosis and other adverse tissue reactions, as effectively as premature device failure. According to the June 17th Memorandum, the Biomet hip replacement litigations next case management conference has been scheduled for September 23, 2013, whilst a telephonic status conference is set for July 29, 2013.

&#13

The U.S. Meals &amp Drug Administration (FDA) has been reviewing the security of metal-on-metal hip implants like the Biomet M2a Magnum considering that February 2011. In January, the FDA warned that the metal debris shed from these devices can trigger damage to bone and/or tissue surrounding the implant and joint, top to discomfort, implant loosening, device failure, and the want for revision surgery to replace the device. At that time, the agency advised recipients of metal-on-metal hip replacements to undergo metal ion testing if they are experiencing symptoms of hip implant failure. The FDA also stated it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which allowed such devices to come to market place with out first undergoing human clinical trials.*

&#13

Alleged victims of metal-on-metal hip implant complications associated to the Biomet M2a Magnum hip could be entitled to compensation for their medical expenditures, lost wages and discomfort and suffering. To understand far more about the Biomet hip replacement litigation, please check out Bernstein Liebhard LLPs website. For further data about filing a Biomet hip lawsuit, please contact 1 our attorneys today at 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated individual and class action lawsuits nationwide given that 1993, such as these who have been harmed by dangerous drugs, defective health-related devices and customer merchandise. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Advertising.

Transvaginal Mesh Lawsuit News: Federal Judge Overseeing American Healthcare Systems Surgical Mesh Lawsuits Selects Bellwether Instances, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) July 02, 2013

Transvaginal mesh lawsuit claims involving items manufactured by American Medical Systems, Inc. continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Pretrial Order issued by the Court on July 1, 2013, four surgical mesh lawsuits have been chosen for the litigations bellwether trials. The proceedings initial trial is scheduled to start on December 3, 2013, even though a second is slated to start off on Might six, 2014. U.S. District Judge Joseph R. Goodwin will soon establish which of the 4 bellwether instances will go to trial on those dates, according to the Order. (In Re: American Health-related Systems, Inc., Pelvic Repair Systems Items Liability Litigation – MDL No. 2325)

&#13

We are incredibly pleased to see these claims moving forward. The bellwether trials will give important clues into how other juries may possibly weigh claims in similar surgical mesh lawsuits involving American Medical Systems, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and health-related devices. The Firms vaginal mesh lawyers are currently representing hundreds of girls who allegedly suffered mesh erosion, discomfort, scarring, infection and other serious injuries, allegedly due to transvaginal mesh merchandise marketed by American Health-related Systems and other manufacturers. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs Steering Committee in the American Healthcare Systems litigation.

&#13

American Health-related Systems Transvaginal Mesh Lawsuits

&#13

Court documents indicate that a lot more than 7,700 surgical mesh lawsuits have been filed against American Healthcare Systems in the Southern District of West Virginia. All of the lawsuits pending in the litigation allege that American Healthcare Systems failed to provide adequate warnings with regards to the dangers linked with surgical mesh utilized to treat pelvic organ prolapse and stress urinary incontinence. It is additional alleged that plaintiffs suffered a range of serious complications due to the defective nature of these items, including chronic infections, organ harm, and mesh erosion and shrinkage.

&#13

The litigation surrounding transvaginal mesh devices utilized to treat pelvic organ prolapse and stress urinary incontinence has been expanding given that October 2008, when the U.S. Food &amp Drug Administration (FDA) warned the public that it had received a lot more than 1,000 reports of serious complications linked with vaginal mesh products over a 3 year period.* Less than 3 years later, in July 2011, the FDA warned that complaints related with transvaginal prolapse repair had grown 5-fold because the 2008 alert, and stated that it no longer regarded as these varieties of injuries to be uncommon.**

&#13

American Healthcare Systems is just 1 of many producers involved in litigations for surgical mesh lawsuits established in the Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs Steering Committees for proceedings involving Boston Scientific Corp., (MDL No. 2326) C.R. Bard, Inc., (MDL No. 2187), and In re: Ethicon, Inc. (MDL No. 2327). Court documents show that the very first of the litigations bellwether trials, involving a C.R. Bard product, is scheduled to start on July 8, 2013.

&#13

Mr. Grand has also been named Co-Liaison Counsel in two consolidated litigations established for C.R. Bard and Ethicon transvaginal mesh lawsuits that are at present underway in New Jerseys Atlantic County Superior Court. He was also a member of the trial group on the very first Ethicon trial in that proceeding, which ended in March with an $ 11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-ten In re: Pelvic Mesh Litigation/Bard, No. L-6339-ten)

&#13

Ladies who have allegedly suffered severe complications related with transvaginal mesh may possibly be entitled to compensation for their healthcare bills, discomfort and suffering, and other injuries. A wealth of data with regards to transvaginal mesh lawsuits is obtainable at Bernstein Liebhard’s web site. To arrange for a free of charge legal consultation with an experienced mesh lawyer, please get in touch with the Firm these days by calling 800-511-5092.

&#13

*fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079028.htm&#13

**fda.gov/MedicalDevices/Security/AlertsandNotices/PublicHealthNotifications/ucm061976.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated person and class action lawsuits nationwide given that 1993, such as these who have been harmed by dangerous drugs, defective healthcare devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.

Transvaginal Mesh Lawsuits Improve as Statute of Limitations Approaches, Notes Rottenstein Law Group LLP


(PRWEB) July 02, 2013

A two-year bar for making claims approaches this month for transvaginal mesh lawsuits in some states, which has led far more men and women recently to file lawsuits with the aid of attorneys such as the Rottenstein Law Group LLP, a vaginal mesh law firm. There are presently about 16,000 transvaginal mesh lawsuits in federal courts, according to court records.

&#13

On July 13, 2013, it will have been two years since the U.S. Meals and Drug Administration issued a drug safety communication* indicating that the dangers of transvaginal mesh, used to treat pelvic organ prolapse and anxiety urinary incontinence, are not uncommon. Though states statutes of limitation for claims might differ, several states set the limit to two years following an FDA alert, according to court documents in pelvic repair system liability litigations in the consolidation in the U.S. District Court for the Southern District of West Virginia (MDLs 2440, 2187, 2325, 2326, 2327 and 2387).

&#13

These limits are quite crucial. Those who think their mesh implant has harmed them must speak to a lawyer about the applicable statute of limitations for claims, said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. Very carefully contemplating regardless of whether or not to file a lawsuit to recover compensation is a need to, but waiting as well extended could mean losing any opportunity at that compensation.

&#13

Recently, lawsuits against Cook Healthcare, Inc., joined those against C.R. Bard, American Health-related Systems, Boston Scientific, Ethicon and Coloplast in a federal consolidation of lawsuits for pretrial efficiency, according to court documents.

&#13

On July 1, the federal court chose four separate surgical mesh lawsuits as bellwether trials in the AMS MDL. The very first trial is set for Dec. three. Plaintiffs in the six MDLs allege that their mesh implants have brought on them to endure adverse side effects, including erosion, bleeding, pain and infection, according to the court documents.

&#13

The Rottenstein Law Group LLP encourages these who are interested in a lot more details to visit its transvaginal mesh FAQ web page.

&#13

*http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm

&#13

About THE ROTTENSTEIN LAW GROUP LLP&#13

The Rottenstein Law Group LLP is a New York-primarily based firm that represents consumers nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has far more than two decades of experience as a lawyer, to represent clientele hurt by defective health-related devices and drugs. (Lawyer advertising. Prior outcomes do not assure a related outcome.)

&#13

Speak to:&#13

The Rottenstein Law Group LLP&#13

Rochelle Rottenstein, Esq.&#13

321 W. 44th Street&#13

# 804&#13

New York NY 10036&#13

(212) 933-9500 (workplace phone)&#13

(212) 933-9980 (facsimile)&#13

rochelle (at) rotlaw (dot) com

&#13

###

&#13
&#13
&#13
&#13
&#13

Find A lot more Administrator Press Releases

DePuy Pinnacle Lawsuits Continue to Mount, as Federal Claims Exceed 4,400, Bernstein Liebhard LLP Reports


New York, NY (PRWEB) July 03, 2013

DePuy Pinnacle lawsuit claims involving an all-metal version of the DePuy Pinnacle Hip Replacement Program continue to mount in the federal multidistrict litigation underway in U.S. District Court, Northern District of Texas, Bernstein Liebhard LLP reports. According to a Master Case List issued by the Court on July 1, 2013, 4,445 DePuy Pinnacle hip replacement lawsuits were pending in the proceeding as of June 30th. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244 N.D. Texas)

&#13

Our Firm continues to receive inquiries from individuals who have suffered metallosis, premature device failure and other serious complications allegedly related with the metal-on-metal DePuy Pinnacle hip replacement. We anticipate that filings in this litigation will continue to increase in the coming months, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and health-related devices. Jeffrey S. Grand, a companion with Bernstein Liebhard LLP, serves on the Plaintiffs Steering Committee for the federal litigation, while the Firms DePuy Pinnacle lawyers continue to offer you cost-free legal evaluations to alleged victims of severe complications connected with the all-metal DePuy Pinnacle Hip Replacement Method.

&#13

DePuy Pinnacle Hip Replacement Lawsuits&#13

All of the DePuy Pinnacle hip replacement lawsuits pending in the Northern District of Texas involve a version of the Pinnacle hip method that utilized the Ultamet liner. According to court documents, plaintiffs allege that they have suffered premature implant failure, metallosis and other serious complications due to the propensity of the device to shed dangerous amounts of metal ions into the tissue surrounding the implant, as effectively as the blood stream. The lawsuits further allege that the all-metal Pinnacle shares some of the same style flaws that prompted DePuy Orthopaedics to recall its ASR line of metal hip implants in 2010, and question no matter whether this version of Pinnacle program must have been recalled as properly.

&#13

Even though it does not seem that a DePuy Pinnacle recall is imminent, DePuy Orthopaedics did announce in May possibly that it would be ending sales of all-metal hips, which includes the metal-on-metal Pinnacle. While the firm did not cite the increasing number of DePuy Pinnacle hip replacement lawsuits as a contributing issue to this selection, it did note that demand for metal-on-metal hips has slipped in recent years. According to a May 17th report from The New York Occasions, DePuy also cited a proposed regulation from the U.S. Food &amp Drug Administration (FDA) that would demand the producers of metal-on-metal hips at the moment on the industry to conduct post-marketplace safety research in order to preserve promoting the goods.*

&#13

Victims of significant complications allegedly associated with the metal-on-metal DePuy Pinnacle hip implant may possibly be entitled to compensation for their healthcare care, discomfort and suffering, and other damages. Added details about filing a DePuy Pinnacle hip replacement lawsuit is offered at Bernstein Liebhards site. For a free, no obligation legal consultation with a DePuy Pinnacle lawyer, please call 800-511-5092 today.

&#13

*nytimes.com/2013/05/17/company/jj-is-phasing-out-metal-replacement-hips.html?ref=health&amp_r=

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide since 1993, which includes these who have been harmed by dangerous drugs, defective health-related devices and customer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Advertising.

Mirena Lawsuits Move Ahead, as Case Management Conference is Convened in New Jersey Litigation, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) July 04, 2013

Mirena lawsuit claims filed on behalf of ladies who have allegedly suffered significant complications, such as spontaneous device migration and uterine perforations, due to their use of the IUD, are moving forward in each state and federal courts, Bernstein Liebhard LLP reports. Court documents indicate that a Case Management Conference was held on July 1st in the consolidated litigation established for Mirena IUD lawsuits in New Jerseys Bergen County Superior Court. According to an Order issued by the Court on July 2nd, attorneys for the parties have been directed to meet and confer within 30 days to reach agreement on a quantity of issues, including the status, scope, parameters and timing of discovery. The Court also scheduled the litigations next Case Management Conference for August 13, 2013. (In Re: Mirena Litigation Case No. 297)

&#13

Our Firm is actively representing women in Mirena lawsuits, and we continue to hear from alleged victims of critical Mirena complications, including spontaneous device migration and uterine perforations. We are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to provide free of charge legal evaluations to alleged victims of Mirena side effects.

&#13

Mirena IUD Lawsuits&#13

The Mirena IUD was approved by the U.S. Food &amp Drug Administration (FDA) as a birth control strategy in 2000, and later as a remedy for heavy menstrual bleeding in females who wish to use an IUD as their main form of birth handle. According to court documents, Mirena lawsuits allege that Bayer Healthcare Pharmaceuticals downplayed its severe risks and failed to supply sufficient warnings concerning the prospective for spontaneous migration of the Mirena IUD. In addition to the consolidated litigation now underway in New Jersey Superior Court, a multidistrict litigation was not too long ago established in U.S. District Court, Southern District of New York for all federally-filed Mirena IUD lawsuits. A Status Conference in the federal multidistrict litigation was held on July 2nd. (In re: Mirena IUD Items Liability Litigation, MDL No. 2434)

&#13

According to a June 17th report from NewsChannel5 in Cleveland, the FDA has received more than 70,000 adverse occasion reports involving Mirena given that the device was launched in 2000. Information from the FDA also indicated that given that 2008, the agency had received a lot more than 4,700 complaints of device dislocation involving Mirena, and 1,300 reports of uterine perforations. Despite these mounting adverse event reports, there has been no indication that Bayer may be arranging to announce a Mirena IUD recall any time in the future.*

&#13

Whilst a Mirena recall does not appear imminent, the FDA has taken problem in the past with some of the claims Bayer has utilised in marketing campaigns for the IUD. In 2009, the agency issued a warning letter to Bayer after obtaining that its Mirena promotions overstated the efficacy of the device and minimized its dangers. Amongst other items, the letter cited Bayer for producing statements that indicated that Mirena would assist a lady look and really feel wonderful, and enhance her sex life.**

&#13

Ladies who have allegedly suffered significant Mirena complications following spontaneous migration of the IUD may be entitled to compensation for their health-related bills, lost wages, discomfort and suffering and other damages. To find out a lot more about Mirena lawsuits, please go to Bernstein Liebhard LLPs site. To arrange for a cost-free evaluation of your potential Mirena IUD lawsuit, please contact 800-511-5092.

&#13

*newsnet5.com/dpp/news/local_news/investigations/thousands-of-females-complain-about-harmful-complications-from-mirena-iud-birth-handle&#13

*http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM197229.pdf

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide because 1993, such as these who have been harmed by harmful drugs, defective medical devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.

Medtronic Infuse Bone Graft Failure Allegation Lawsuits Update: Resource4thePeople Reports New Analysis Findings Raise Issues about Side Effects

San Diego, CA (PRWEB) July 05, 2013

http://www.resource4thepeople.com/defectivemedicaldevices/medtronic.html

&#13

Resource4thePeople, in its latest update to customers impacted by operations involving healthcare devices, these days announced that the findings of a two-year study by Yale University researchers have raised issues about the marketing and advertising and security of Medtronic Infuse bone grafts similar to those integrated in allegations now being reviewed.

&#13

The Yale University study, which was published* June 18, 2013 in the Annals of Internal Medicine, was undertaken as an independent study following the health-related devices were the topic of a Class 1 Recall by the Meals and Drug Administration** and a highly vital report*** from a U.S. Senate committee that raised concerns about conflicts of interest simply because of payments the organization produced to health-related researchers and physicians.

&#13

Studies funded by Medtronic underplayed the advantages of the Infuse bone grafts and failed to report numerous critical side effects, according to both Yale researchers and Senate investigators. The Yale researchers reported such severe side effects as excessive bone development, male sterility, inflammations and paralysis, according to the report.

&#13

The findings of this study are constant with some of the allegations that we have been getting in rising numbers considering that the release of the Senates report, said Resource4thePeople.

&#13

We anticipate that the news of the Yale researchers findings will generate even a lot more inquiries from customers about the legal possibilities they might have to seek compensation and consequently, we will continue to provide totally free legal consultations and overview these claims.

&#13

The Yale researchers had been crucial of prior Medtronic-funded study research which provided endorsements of the safety and effectiveness of the Infuse bone grafts. The Yale researchers help those research had been biased, as did Senate investigators in their report.

&#13

The Yale researchers summarized their findings in comparing the Medtronic Infuse bone graft (rhBMP-2) to conventional therapy by saying:

&#13

In conclusion, we discovered substantial proof of reporting bias and no proof that rhBMP-2 is a lot more effective than ICBG in spinal fusion, with some evidence of an association with crucial harms. Far more study is needed to offer a lot more trustworthy estimates of danger for cancer and other adverse events and to determine patient populations in which use of rhBMP-two could be beneficial, such as circumstances where use of bone graft alone is related with a high danger for pseudarthrosis. On the basis of the currently offered evidence, it is difficult to recognize clear indications for rhBMP-two in spinal fusion.

&#13

Resource4thePeople stated it will also continue to offer normal updates supplying buyers who might have been impacted by remedy with Medtronic Infuse bone grafts with data about research and legal developments involving the devices.

&#13

This will continue to be an region of prime concentrate for us as we provide buyers legal options involving allegations that the Medtronic Infuse Bone Grafts might have caused critical, life-threatening health issues, mentioned Resource4thePeople.

&#13

Amongst the allegations we are investigating are claims from buyers alleging that the Medtronic Infuse Bone Grafts had been utilised improperly in medical operations and caused serious side effects to sufferers.

&#13

Resource4thePeople also mentioned that its national network of attorneys will continue to review claims from customers who are alleging they could have suffered extreme back and leg discomfort, infections, bone deterioration, sterility and cancer, amongst other troubles.

&#13

In the FDAs Feb. 16, 2011 Class 1 Recall** of Medtronic Infuse Bone Graft pumps and refill kits, the FDA warned that the merchandise “may outcome in patient harm, serious injury, and/or death due to drug overdose or underdose.

&#13

Class I recalls are the most severe variety of recall and involve situations in which there is a reasonable probability that use of these merchandise will lead to significant adverse overall health consequences or death.

&#13

Resource4thePeoples legal group is also investigating claims similar to those contained in a federal lawsuit**** filed in March in the Southern District of Ohio against Medtronic Inc. and an Ohio surgeon who, according to complaint, was a paid Medtronic consultant in addition to his professional duties.

&#13

The lawsuit includes allegations that 88 sufferers are claiming that underwent spine surgeries involving bone protein that they did not consent to and have suffered detrimental side effects for which they are searching for compensation.

&#13

The lawsuit claims that “medically unnecessary, experimental spine surgeries” had been performed “using falsely and improperly marketed Medtronic healthcare devices and drugs,” according to allegations contained in the court file.

&#13

Resource4thePeople also stated that the allegations filed in the lawsuit raise far more inquiries about the relationships between physicians and Medtronic over costs paid to the medical doctors that have come beneath criticism from the U.S. Senate Finance Committee investigators.

&#13

The revelations integrated in the Oct. 25, 2012 report by the Senate Finance Committee involving payments to doctors and the downplaying of dangerous side effects from this healthcare device have raised significant questions amongst patients who underwent these surgeries and have contacted us,” mentioned Resource4thePeople.

&#13

Resource4thePeople said that over the final few months such inquiries have enhanced as a outcome of news media reports about the findings of the committees investigation into Medtronics spending of millions of dollars to physicians and researchers in return for studies favorable to the Infuse device.

&#13

The Medtronic Infuse bone graft was approved by the Food and Drug Administration as a sanctioned medical device made to stimulate spinal bone development in individuals suffering from reduce spine degenerative diseases.

&#13

Sources:&#13

*http://annals.org/post.aspx?articleid=1696646&#13

**http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm243634.htm&#13

***http://www.finance.senate.gov/newsroom/chairman/release/?id=b1d112cb-230f-4c2e-ae55-13550074fe86&#13

****Case # 1:13cv0202 U.S. District Court, Southern District of Ohio

&#13
&#13
&#13
&#13
&#13

Much more Administrator Press Releases

DePuy Pinnacle Hip Implant Lawsuits Rising, Notes Rottenstein Law Group LLP


(PRWEB) July 02, 2013

DePuy Pinnacle lawsuits are creating their way by way of federal courts. The attorneys at Rottenstein Law Group LLP note that the quantity of DePuy Pinnacle injury lawsuits has elevated over the course of 2013, according to court documents in In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation (MDL-2244 U.S. District Court for the Northern District of Texas).

&#13

There are about 4,000 consolidated into a multidistrict litigation for pretrial efficiency, according to court documents. As they have with other metal-on-metal hip replacement systems, plaintiffs in the Johnson &amp Johnson DePuy Pinnacle instances have filed lawsuits alleging they suffered from a number of side effects, such as metal poisoning (metallosis) and device failure, according to court documents.

&#13

The Pinnacle, like the DePuy ASR hip implant, has been under U.S. Food and Drug Administration scrutiny due to the fact of the possible for the metal components of the implant to rub collectively, causing cobalt and chromium ions to flake off into the implant recipients bloodstream. That causes the metal poisoning, which could result in some implant recipients suffering from so-called pseudotumors. *

&#13

These who think their hip implants have injured them deserve to have the chance to pursue compensation for their harms, stated Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. Published study studies and FDA security communications all serve as possible evidence at trialand could serve to inspire far more implant recipients to file lawsuits.

&#13

The Rottenstein Law Group LLP represents customers in Pinnacle and other metal-on-metal hip implant lawsuits. The firm encourages those who think they have suffered from the Pinnacles alleged side effects to pay a visit to its FAQ web page to discover more about the side effects and eligibility for filing a lawsuit.

&#13

*bloomberg.com/news/2013-02-21/j-j-s-floyd-says-hip-sales-halted-for-business-not-security.html

&#13

About THE ROTTENSTEIN LAW GROUP LLP&#13

The Rottenstein Law Group LLP is a New York-primarily based firm that represents consumers nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clientele hurt by defective health-related devices and drugs. (Attorney marketing. Prior final results do not assure a related outcome.)

&#13

Get in touch with:&#13

The Rottenstein Law Group LLP&#13

Rochelle Rottenstein, Esq.&#13

321 W. 44th Street&#13

# 804&#13

New York NY 10036&#13

(212) 933-9500 (workplace telephone)&#13

(212) 933-9980 (facsimile)&#13

rochelle (at) rotlaw (dot) com

&#13

KEL Attorneys Files Groundbreaking Lawsuits to Represent California Property owners Facing Foreclosure

Orlando, FL (PRWEB) October 14, 2009 –

The Law offices of Kaufman, Englett and Lynd LLC, (KEL Attorneys), the nation’s expert law firm in foreclosure defense and loan modifications, is now representing California home owners facing foreclosure. KEL will set instances in motion by filing lawsuits on behalf of homeowners against lenders. Homeowner’s legal claims against lenders will be based on TILA Violations, RESPA Violations, Fraud in the Inducement and Predatory Lending Practices.

&#13

California is a non-judicial state. In non-judicial states, the lender is not necessary to pursue cases via the court technique before selling a house in a foreclosure sale. KEL Attorneys will move for injunctive relief so the lender is prevented from proceeding with the foreclosure until the property owners claims are heard by a judge. We will file in state court and federal court if necessary.

&#13

KEL Attorneys will be the very first law firm to file these lawsuits on a enormous scale. These lawsuits could adjust the way foreclosures are handled in the State of California for the foreseeable future. For much more data on these groundbreaking lawsuits please contact Matt Harrison at 407-513-1900 ext. 7159.

&#13

###

&#13
&#13
&#13
&#13
&#13

Much more Loan Modification Press Releases

Mirena IUD Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Case Management Conference in Federal Mirena Side Effects Litigation


New York, New York (PRWEB) June 23, 2013

Mirena IUD lawsuit claims continue to move forward in the federal multidistrict litigation underway in U.S. District Court Southern District of New York. According to court documents, the subsequent Status Conference in the federal Mirena side effects litigation is scheduled for July 1, 2013. So far, practically 50 claims have been filed in the Southern District of New York on behalf of women who suffered spontaneous device migration, uterine perforations, and other injuries, allegedly due to the Mirena IUD. (In re: Mirena IUD Items Liability Litigation, MDL No. 2434)

&#13

We continue to hear from women who allegedly suffered significant Mirena side effects. We appear forward to additional progress in this litigation in the coming months, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm continues to provide free Mirena lawsuit consultations to ladies who have been allegedly harmed as a outcome of spontaneous migration of the Mirena IUD.

&#13

Mirena Lawsuits&#13

The Mirena IUD was authorized by the U.S. Meals &amp Drug Administration (FDA) as a birth control strategy in 2000. In 2009, Mirenas authorized makes use of have been expanded to consist of therapy of heavy menstrual bleeding in females who wish to use an IUD as their approach of birth control. NewsChannel5 in Cleveland, Ohio reported on June 17th that a lot more 70,000 adverse event reports involving the Mirena IUD have been logged with the FDA because 2000, such as thousands involving device dislocation and uterine perforations.*

&#13

Court filings indicate that plaintiffs in Mirena lawsuits are alleged to have suffered severe injuries due to spontaneous migration of the IUD. Claims further allege that Bayer Healthcare Pharmaceuticals downplayed potential Mirena side effects and failed to offer adequate warnings with regards to the prospective for spontaneous device migration. In addition to the federal litigation now underway in the Southern District of New York, at least 100 Mirena IUD lawsuits have been filed in a consolidated litigation underway in New Jerseys Bergen County Superior Court. (In Re: Mirena Litigation Case No. 297)

&#13

Alleged victims of Mirena side effects might be eligible to file claims in either of these litigations if they suffered from injuries related to spontaneous migration of the IUD. Understand a lot more about Mirena lawsuits by going to Bernstein Liebhard LLPs website. For added information, please call 800-511-5092.&#13

&#13
newsnet5.com/dpp/news/local_news/investigations/thousands-of-women-complain-about-unsafe-complications-from-mirena-iud-birth-manage

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complicated person and class action lawsuits nationwide given that 1993, like those who have been harmed by unsafe drugs, defective medical devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the prime plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Ethicon Vaginal Mesh Lawsuits Continue, as Claims in New Jersey Litigation Exceed 3,000, Bernstein Liebhard LLP Reports


New York, NY (PRWEB) June 21, 2013

Vaginal mesh lawsuit filings involving Ethicon Inc.s Gynecare pelvic mesh items continue to mount in a consolidated litigation underway in New Jerseys Atlantic County Superior Court, Bernstein Liebhard LLP reports. According to the most recent Case List issued by the Court, 3,017 claims have been filed in the New Jersey Ethicon litigation on behalf of alleged victims of vaginal mesh complications. Firm partner, Jeffrey S. Grand, is serving as Co-Liaison Counsel for this litigation. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-ten).

&#13

It is not at all surprising that the vaginal mesh lawsuits filed in the New Jersey Ethicon litigation have reached this milestone. Practically two years following the FDA issued its final public overall health notification with regards to the risks linked with transvaginal mesh, we continue to hear from alleged victims of vaginal mesh complications on a standard basis, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm continues to evaluate transvaginal mesh lawsuits on behalf of women allegedly injured by pelvic mesh products marketed by Ethicon, Inc. and other companies.

&#13

Vaginal Mesh Complications&#13

Concerns over complications related with transvaginal mesh devices have been mounting considering that October 2008, when the U.S. Meals and Drug Administration (FDA) alerted the public that it had received much more than 1,000 adverse occasion reports involving individuals who had received the implants to treat pelvic organ prolapse and anxiety urinary incontinence. In July 2011, the FDA issued a second alert after such reports improved by five-fold, with the regulator now warning that the frequency of complications related with transvaginal prolapse repair was not rare. According to the agency, the most frequently reported vaginal mesh complications contain mesh erosion via the vaginal epithelium, pain, urinary difficulties and infection.*

&#13

In March, the Plaintiff in the initial Ethicon mesh lawsuit to head to trial in the U.S. was awarded more than $ 11 million, like $ 7.76 million in punitive damages, after a jury in New Jersey Superior Court discovered that patients were not properly warned about the risks associated with the Gynecare Prolift device. Jeffrey S. Grand also served on the Plaintiffs trial group for this case. (Gross v. Gynecare Inc., Atl-L-6966-ten, Superior Court of Atlantic County, New Jersey)

&#13

Mr. Grand is also serving as Co-Liaison Counsel for a consolidated litigation underway in Atlantic County Superior Court for lawsuits involving pelvic mesh manufactured by C.R. Bard Inc. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-ten), and is a member of the Plaintiffs Steering Committees in four federal transvaginal mesh multi-district litigations underway in U.S. District Court, Southern District of West Virginia. These proceedings incorporate: In re: Boston Scientific Corp., Pelvic Repair Systems Goods Liability Litigation (MDL No. 2326) In re: C.R. Bard, Inc., In Re: American Healthcare Systems, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2325) In re: C.R. Bard, Inc., Pelvic Repair Systems Items Liability Litigation (MDL No. 2187) and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2327). The 1st trial in that litigation, involving a C.R. Bard vaginal mesh lawsuit, is scheduled to begin on July 8, 2013.

&#13

Alleged victims of vaginal mesh injuries might be eligible to seek compensation for health-related costs, discomfort and suffering and other damages. Learn a lot more about how to file a vaginal mesh lawsuit by going to Bernstein Liebhard’s internet site, or by contacting one particular of the Firms attorneys straight at 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide given that 1993, including those who have been harmed by dangerous drugs, defective medical devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the prime plaintiffs firms in the nation, for the past ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

(800) 511-5092

&#13

Attorney Advertising.